Literature DB >> 4322850

Method for the preparation of a herpesvirus hominis fluorescent conjugate for direct immunofluorescence.

M I Marks.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4322850      PMCID: PMC7086609          DOI: 10.1007/bf01250065

Source DB:  PubMed          Journal:  Arch Gesamte Virusforsch        ISSN: 0003-9012


× No keyword cloud information.
  5 in total

1.  FLUORESCENT ANTIBODY STUDY OF HERPES SIMPLEX VIRUS LESIONS AND RECURRENT APHTHAE.

Authors:  J W GRIFFIN
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1963-08

2.  THE FLUORESCENT ANTIBODY TECHNIQUE IN DIAGNOSIS OF HERPES SIMPLEX KERATITIS.

Authors:  T H PETTIT; S J KIMURA; H PETERS
Journal:  Arch Ophthalmol       Date:  1964-07

3.  Rapid diagnosis of herpes simplex virus infections with fluorescent antibody.

Authors:  J Z BIEGELEISEN; L V SCOTT; V LEWIS
Journal:  Science       Date:  1959-03-06       Impact factor: 47.728

4.  The diagnosis of corneal herpes simplex infection by fluorescent antibody staining.

Authors:  H E KAUFMAN
Journal:  Arch Ophthalmol       Date:  1960-09

5.  Application of the Weichselbaum biuret reagent to the determination of spinal fluid protein.

Authors:  M DITTEBRANDT
Journal:  Am J Clin Pathol       Date:  1948-05       Impact factor: 2.493

  5 in total
  3 in total

1.  Detection of genital herpes simplex infections by a tissue culture-fluorescent-antibody technique with biotin-avidin.

Authors:  L S Nerurkar; A J Jacob; D L Madden; J L Sever
Journal:  J Clin Microbiol       Date:  1983-01       Impact factor: 5.948

2.  Passive immunization in experimental Herpesvirus hominis infection of newborn mice.

Authors:  F Luyet; D Samra; A Soneji; M I Marks
Journal:  Infect Immun       Date:  1975-12       Impact factor: 3.441

3.  Comparison of standard tissue culture, tissue culture plus staining, and direct staining for detection of genital herpes simplex virus infection.

Authors:  L S Nerurkar; M Namba; J L Sever
Journal:  J Clin Microbiol       Date:  1984-05       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.